Oasmia Pharmaceutical Ab (OASM) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access OASM Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Oasmia Pharmaceutical Ab.
Quarterly Report, GAAP in USD millions
ITEM
(Apr 30 2018)
0 0 0 (Apr 30 2017)
Assets
Cash, Cash Equivalents Other1.78
Cash & Short-term Investments1.00
Accounts receivable0.18
Notes Receivable, Current0.00
Inventories1.11
Other Current Assets0.00
Total Current Assets9.19
Equipment/Property/Plant Net1.77
Intangible Assets5.24
Other Assets, Noncurrent568.08
Total Assets64.83
Liabilities
Accounts Payable1.06
Other Liabilities, Current0.00
Total Current Liabilities25.45
Total Long-term Debt0.00
Other liabilities, Noncurrent223.04
Total Liabilities25.45
Stockholders' Equity
Common Stockholder's Equity0.00
Total Stockholder's Equity39.37
Liabilities & Stockholder's Equity64.83
4 historic quarters locked

Sign in to unlock the full Oasmia Pharmaceutical Ab balance sheet history.

About OASM Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License